IL2 and neoplasm: Interestingly, Esteva-Lorenzo et al. published a case report in 1995 reporting the first case of necrotizing myositis in a patient with metastatic renal cell carcinoma undergoing treatment with HD-IL2 after autologous tumor vaccine [25].